It is an unsettling question that has emerged alongside the extraordinary rise of the new generation of weight-loss drugs.
Employer coverage of GLP-1 drugs is collapsing heading into 2027, but the FDA just gave Eli Lilly a specific piece of ...
The FDA has approved Mounjaro to reduce cardiovascular risk in people with type 2 diabetes after a major trial found it ...
By Nqobile Dludla JOHANNESBURG, Sept 3 (Reuters) - Aspen Pharmacare expects African sales of Eli Lilly's blockbuster weight-loss and diabetes drug Mounjaro to exceed 2 billion rand ($124 million) in ...
(This Aug 28 story has been repeated with no changes to text.) Aug 28 (Reuters) - Eli Lilly said on Friday the U.S. FDA has ...
The FDA approved Eli Lilly's diabetes drug Mounjaro to cut down the risk of heart attack or stroke in high-risk adults with ...
Industry stakeholders want the US Food and Drug Administration (FDA) to expand the scope of its recent draft guidance on the types of scientifically valid prior knowledge sponsors may consider when ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results